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Abstract  
Background: The increased proportion of UK children diagnosed with autism 
spectrum disorder (ASD) has been attributed to improved identification, rather than 
true increase in incidence. 
Aim: To explore whether the proportion of children with diagnosis of ASD and/or the 
proportion with associated behavioural traits had increased over a ten year period.  
Method: A cross-cohort comparison using regression to compare prevalence of 
diagnosis and behavioural traits over time. Participants were children aged 7 years 
assessed in 1998/9 (n = 8,139) and 2007/8 (n=13,831).  
Results: During 1998/9, 1.09% (95% CI: 0.86-1.37), of children were reported as 
having ASD diagnosis compared to 1.68% (95% CI: 1.42-2.00) in 2007/8: Risk Ratio 
(RR)= 1.55 (95% CI: 1.17-2.06). The proportion of children in the population with 
behavioural traits associated with ASD was also larger in the later cohort: RR=1.61, 
(1.35-1.92). 
Conclusions: Increased ASD diagnosis may partially reflect increase in rates of 
behaviour associated with ASD and/or greater parent/teacher recognition of 
associated behaviours.  
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Introduction. 
The number of children diagnosed with autism spectrum conditions over the 
last 40 years has increased substantially (1). When the first UK prevalence study 
was conducted, autism was thought to be a rare condition that occurred in 1 child per 
2500 (2). Today, estimates suggest at least 1 in 100 children have an autism 
spectrum disorder (ASD) (3). Latest US parent report estimates are that one in 68 
children (1.5%) are diagnosed with ASD by age eight (4), although the trend for 
increasing diagnosis may be levelling off in the UK (5). The reasons behind the rising 
rate of diagnosis of ASD are hotly debated. The crux of the debate is whether 
increases are entirely an artefact of changing diagnostic practice, greater awareness 
and different methodologies used to estimate prevalence, or whether there is a true 
increase in the incidence, i.e. there is an increase in the number of children with 
behaviours that underlie autism. Revisions to diagnostic criteria certainly provide a 
partial explanation. For example, the inclusion of Asperger’s syndrome in the 
Diagnostic and Statistical Manual of Mental Disorders (DSM-IV) in 1994 meant that 
more children were identified in the ASD category. Moreover, there is greater 
awareness of the condition both at home and in the clinic (6), particularly after media 
exposure and the work of ASD charities. It has been argued there is no ‘epidemic’ of 
autism and that apparent rises in prevalence can be attributed to the combination of 
children with milder difficulties receiving the diagnosis due to broadened diagnostic 
criteria, greater public and clinical awareness and improved case identification 
including diagnosis of children with typical attainment (7). However, many people 
affected by these conditions, particularly parents, clinicians and educators believe 
that as well as changes in diagnostic practice and increasing awareness  there is 
additionally a true rise in the underlying incidence of ASD (8). As the DSM-5 puts it: 
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‘it remains unclear whether higher rates reflect an expansion of the diagnostic criteria 
of DSM-IV to include sub-threshold cases, increased awareness, differences in study 
methodology or a true increase in the frequency of autism spectrum disorder' (9). 
Our objectives were therefore a) to confirm an increase in parent-reported 
ASD diagnosis at age seven in the UK between two time points (two population-
based cohorts from 1998/9 and 2007/8), b) to compare the proportions of children 
with behaviours associated with autism over the same time period, and c) to 
reassess the increase in rate of diagnosis of ASD after accounting for any change in 
the proportion of children with behaviour associated with autism. In light of recent 
discussions about the under-identification of ASD in females (10) and the diagnosis 
of younger children (7) a secondary aim was to check whether any increase in 
diagnosis over time was proportionally the same for females and younger children. 
Method 
The study used a cross-cohort comparison design utilising ‘like-for-like’ 
closely similar or identical measures related to ASD type behaviour and repeated 
across two unselected population cohorts. The like-for-like approach aims to utilise 
the same tools of measurement in two or more population-based birth cohorts in 
which children are born at different times. The aim is assess time trends: ideally 
constructs of interest should be measured by exactly the same instruments in each 
cohort, and administered in the same way, or as near as is possible.  The primary 
advantage of this approach is that ‘like-for-like’ comparisons extend to the whole 
population rather than focusing on selected subgroups seen in clinical practice (11). 
A primary limitation is that comparable measures relate to symptoms and behaviours 
assessed using instruments included in national cohort studies rather than validated 
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assessments of ASD. In this study, we compared two UK birth cohorts in cross-
section when children were age seven or eight years old across a ten-year period 
(1998/9-2007/8). A recent cross national comparison of six successive birth-cohorts 
in Denmark, Australia Finland and Sweden found rates of ASD diagnosis increased 
in children aged seven from 1997/9 through 2006/8 in all four countries (12). 
Samples 
The samples were two UK birth cohorts: the Avon Longitudinal Study of 
Parents and Children (ALSPAC) and the Millennium Cohort Study (MCS). In 
ALSPAC, 99% of children were age seven in 1998 or 1999; in MCS 99% of children 
reached this age in 2007 or 2008. According to our review of UK cohort studies, 
these are the only two recent studies that include information about clinical diagnosis 
of ASD and similar measures of behaviour associated with ASD. 
The ALSPAC cohort is a whole population birth cohort study of pregnant 
women and their children in a defined geographical area of the UK. ALSPAC 
prospectively examines influences on health and development across the life-course. 
All pregnant women resident in the Avon region of South West England were eligible 
for inclusion (just over 20,000) and 14,541 were initially recruited, which resulted in 
14,062 live births in 1991-1992. When children were seven years old, 706 additional 
eligible families were recruited. Details of the measures taken throughout their 
childhood and adolescence have been tabulated elsewhere (13). Social and 
demographic features of the ALSPAC cohort were broadly representative of the 
overall population in the UK as measured by the 1991 UK national census (14). The 
ALSPAC study website contains details of all the data that are available through a 
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fully searchable online data dictionary and gives further details of representativeness 
of the sample. 
The MCS is a UK-representative birth cohort study that used a stratified 
cluster sampling design to examine health and developmental outcomes across the 
life-course of its study children. Children born between 2000 and 2002 and listed on 
the Child Benefit Records, a database registering more than 98% of children in the 
UK, were eligible.  Study design was stratified by UK country (England, Scotland, 
Wales and Northern Ireland), and further stratified by ethnic group and level of social 
disadvantage; details of the sampling design are documented by the curators [16, 
17]. Data has been collected since children were 9 months old. 19,519 families were 
initially recruited to the MCS cohort, and parent report of ASD diagnosis was 
recorded at age seven. Data are freely available to accredited researchers via the 
UK data service website (ukdataservice.ac.uk). 
Ethical approval for the ALSPAC study was obtained from the ALSPAC Law 
and Ethics Committee.  For MCS, written informed consent was obtained from 
parents at each data collection stage for their participation and the participation of 
their child; further details are provided in the MCS ethical review (15). Analyses were 
conducted anonymously, with researchers having no access to participant identities. 
Additional ethical approval for the analyses reported in this study was granted by the 
University of Exeter Medical School Ethics committee. 
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Measures 
Parent-reported ASD diagnosis 
Insert Figure 1 
ASD diagnosis was reported by parents in both cohorts. Figure 1 shows the 
exact wording of the question presented to the parents and the response categories. 
‘Autism Spectrum Disorder’ is adopted throughout this article to describe autism 
spectrum conditions as this was the term used in the MCS questionnaire (see Figure 
1). This question has been used to estimate rates of diagnosis of ASD in the US 
(16). Parent-reported data on ASD diagnosis were collected using a self-completion 
questionnaire in ALSPAC and recorded during face-to-face interviews in the MCS. 
The sample eligible for this analysis was limited to those children whose parents 
reported on ASD diagnosis status.  In addition, the analyses included only one child 
per family (second born twin siblings were excluded) as ASD traits are likely to be 
co-inherited (17). The included study sample size was 8,139 in ALSPAC (60% of 
total sample) and 13,831 in MCS (70% of total sample). Selective attrition was dealt 
with using weightings (see analysis section). Table 1 shows the distribution of early 
predictors of i) the complete early sample, ii) the unweighted analysis sample, and iii) 
the analysis sample (weighted). 
Insert Table 1 
To validate parent-report diagnosis of ASD Parent-report of an autism 
diagnosis was checked against the medical report of clinical ASD diagnosis (which 
was only available in ALSPAC). Clinical ASD diagnosis was obtained from medical 
records (18). Briefly, individuals in the ALSPAC cohort who had a diagnosis relating 
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to any form of developmental delay or listed as special educational needs were 
recorded from the computer systems of relevant NHS trusts. The records were 
matched against the ALSPAC cohort to confirm that the child was a member of the 
study and that permission had been given to search their health records. A team of 
three experienced researchers then searched hospital medical records (in-patient 
and outpatient) and community child-health records (including child development 
team records) to identify children who had a diagnosis of ASD made after a 
multidisciplinary assessment. No direct contact was made with any of the children, 
parents, or clinicians. The sensitivity of parent-report in identifying medical diagnosis 
was 95% and the specificity was 99%, indicating it was a good, but not perfect 
indicator of clinical diagnosis (see on-line supplement Table S1).  
Behaviours associated with autism 
Data on behaviours associated with autism spectrum traits occurring in 
multiple settings were collected in both cohorts via teacher assessments, and by 
parent report. On-line supplement Table S2 shows how measures tapped into the 
three domains of impairment in social skills, impairment in communication and 
adherence to routines listed in ICD-10 ASD criteria (19), and the individual items 
used, and how they were scored.  
Parent and teacher-rated subscales from the Strengths and Difficulties 
Questionnaire (SDQ) of prosocial behaviour, peer problems, and ‘difficulty coping 
with new situations’ (20) were recorded in both cohorts. Answers to SDQ reports 
were given on the basis of the child's behaviour over the last six months or in the 
concurrent school year. We also utilised foundation stage assessments of social 
development and language for communication made by teachers in children’s first 
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year of school (21) which were also were included  in both cohorts. Distributions of 
foundation stage assessment scores of communication and social development from 
educational data in each cohort is given in online supplement Figure S1.  
          
The composite autism trait score (CATS) 
Given that autism is conceptualised as the constellation of difficulties across 
multiple domains of impairment we used the eight measures described above to 
derive a composite autism-type trait score (CATS). First, data was pooled from both 
cohorts and each of the eight indicator measures was standardized (M=0, SD=1). 
Some were reverse-coded so a higher score indicated greater impairment. CATS 
comprised the overall mean score across each of component indicator measures 
(calculated where data was available for a minimum of five indicator scales). This 
resulted in 4,530 children with CATS scores in ALSPAC (56% of the age 7 sample) 
and 11,210 in MCS (81% of the age 7 sample). The CATS score had a positive 
skew-normal distribution. Children with ASD diagnosis mostly appeared at the 
skewed tail end (Figure 2). This method was akin to that initiated in previous work 
(22) but in order to allow cross-cohort comparisons we used an amended approach 
that only incorporated autism-related behaviours recorded in both cohorts. 
Insert Figure 2 
To test whether the same proportion of children had autism-related 
behaviours in 2007/8 as 1998/9, we specified a cut-off (top 5% of CATS score based 
on scores pooled across both cohorts). The top 5% range of CATS was selected as 
it captured 67% of children with a diagnosis of ASD, and the specificity (the 
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percentage of children who were correctly identified as not having the condition) was 
95% (see supplementary resource 4 for cross-tabulation). Figure 2 illustrates the cut-
off point in the pooled study samples. A child above this cut-point likely had poor 
communication, was less able to sustain peer relationships, and/or was afraid of new 
situations and/or did not share easily or empathise well. The category was labelled 
‘high CATS’. 
Statistical analysis 
First, the unadjusted association between individual behavioural sub-scales 
and ASD diagnosis was checked in each cohort. We predicted that these behaviours 
would be strongly associated with the parent-report of ASD diagnosis, and the 
unadjusted association was carried out to check this was the case. Data were pooled 
to include data from both cohorts, then, the percentage of children with a parent-
reported ASD diagnosis and the percentage that had high CATS behaviour above 
cut-off were obtained with 95% confidence intervals. Risk ratios and odds ratios with 
confidence intervals are presented to quantify the prevalence of diagnosis and high 
CATS status in the MCS cohort (reported in 2007/8) relative to the ALSPAC cohort 
(reported in 1998/9). Logistic regression models were fitted to estimate odds ratios 
using the logit function, and risk ratios were estimated with generalized linear 
modelling using a combination approach. These were models with high CATS status 
or ASD diagnosis as the outcome and cohort as the predictor.  
            The revised odds ratio for ASD diagnosis in the MCS cohort relative to the 
ALSPAC cohort was then re-estimated adjusting for both continuous CATS scores 
and high CATS (top 5%) status. If there was a true underlying increase in children 
with ASD then we would expect there to be an increase in the number of children 
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with impaired (top 5%) CATS. Furthermore, we would expect that accounting for 
increase in children high CATS would partially or fully explain increased risk for 
diagnosis in the later cohort.  
MCS supplies weightings to make the sample representative of the UK 
population as a whole at age seven: these take into account the stratified sample, 
over recruitment of sub-groups, and attrition.  In order to account for attrition in 
ALSPAC, non-response weights were derived based on prior predictors of attrition 
available for the whole cohort at birth (maternal education, maternal and paternal 
social class and maternal age at child’s birth) as in previous cross-cohort 
comparisons (23). Table 1 characterises missing data and shows the efficacy of 
weights in addressing selective non-response. Weights shifted the distribution so 
that it was more representative of the sample at birth but did not completely correct 
it. For example, the adjustment did not seem to fully correct for the selective drop-out 
of mothers of lower education.  
A secondary objective was to characterise how children diagnosed with ASD 
differed between 1999/8 and 2007/8 in terms of gender, and age of diagnosis. For 
children with ASD diagnosis only (n=291), Logistic regression with cohort as the 
predictor and child gender, or age of diagnosis as outcomes was carried out. This 
was to establish whether the later time point predicted whether females and/or 
younger children were more likely to receive the ASD diagnosis. 
All analyses were conducted using Stata 13 software. Descriptive statistics 
were generated using weightings and for MCS the UK sampling frame (svy: 
command in Stata). The Odds Ratios (ORs) generated were derived in three ways in 
order to check that estimates were reliable- given that MCS had an integral sampling 
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frame and ALSPAC did not. The ORs were initially derived with and without MCS 
survey frame: i) inserting ALSPAC data into the MCS survey frame, ii) using attrition 
weightings only without any sampling frame and iii) OR estimates were calculated 
manually from descriptive statistics in MCS generated using sampling frame and 
weightings, and using derived weightings for ALSPAC. No discrepancies in results 
were detected using these three divergent methods, despite the use of different 
survey frames in the two cohorts. We therefore concluded estimates of odds ratios 
were reliable. Adjusted analyses were subsequently carried out using the second 
method. 
Results 
All behaviour scales were strongly associated with ASD diagnosis in each 
cohort (Table S4). 
In the 1998 ALSPAC cohort, 1.09% of children were reported to have had an 
ASD diagnosis, 95% CI (0.86 to 1.37). In the 2008 MCS cohort, 1.68% children were 
reported as having an ASD diagnosis, 95% CI: (1.42 to 2.00). Thus odds of a child 
having an ASD diagnosis increased in the later cohort: Odds Ratio (OR) =1.56; (95% 
CI: 1.16 to 2.08), p=0.003. The corresponding increased risk (Risk Ratio, RR) of 
being diagnosed with ASD in the later cohort was 1.55 (95% CI: 1.17 to 2.06), 
p=0.003. 
             In the earlier 1998/9 cohort, 4.26 %, (95% CI: 3.64, 4.98) of children fell in 
the high CATS category; whereas in the 2007/8 cohort, 6.86%, (95% CI: 6.29, 7.49) 
had high CATS traits (top 5%). There was strong evidence to suggest the risk/odds 
of having traits in the top 5% of the CATS score were greater in the later cohort, OR 
=1.65; (95% CI: 1.38 to 1.99)/ RR= 1.61, (1.35 to 1.92), p<0.001.  
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Effect size for increased odds of diagnosis in the later cohort (MCS) relative to 
the earlier cohort (ALSPAC), was reduced and became non-significant at 5% level 
after adjusting for CATS score: OR=1.29, 95% CI (0.94, 1.97), p=0.22, or for high 
CATS status OR=1.17, 95% CI (0.80, 1.72), p=0.41. Together, the adjusted results 
suggest an increased number of children with behaviours associated with autism, 
could be responsible, in part, for the increase in parent-reported ASD diagnosis 
observed between the two cohorts. 
Insert Table 2 
Table 2 illustrates how the characteristics of the diagnosed samples varied 
between cohorts. The proportion of boys with ASD diagnosis was higher than the 
proportion of girls in both cohorts, consistent with well-established gender ratios for 
ASD. No differences were detected in gender ratios of diagnosed children between 
cohorts, suggesting the increased application of the diagnosis was similar for both 
genders, and there was no detectable difference in age of diagnosis. 
Discussion 
In line with other evidence from the UK, our findings confirm that the report of 
an ASD diagnosis by parents was higher in MCS in 2007/8 than in ALSPAC in 
1998/9. Other UK studies based on ASD diagnosis recorded in general practice have 
shown stark increases from 1988-2001, but suggest the trend may have levelled off 
more recently (5). Our data show, according to parent report, children were over one 
and a half times as likely to be diagnosed with an ASD in 2007/8 compared to 
1998/9. The rest of the results shed light as to why this may have occurred.  
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Lower thresholds for diagnosis in successive revision to diagnostic criteria 
meant more children were included in the ASD category throughout the time period 
in question, though a meta-analysis suggests the most recent changes to the 
diagnostic classification system in DSM-5 could result in a decrease in the number of 
children diagnosed in future (24). However, our main finding implies that increasing 
rates of ASD diagnosis in the UK over this period may not be solely an artefact of 
changing diagnostic practice and clinical recognition, but there may be an increase in 
the proportion of children with associated behaviours. Instead there may also be an 
increase in the proportion of children in the general population with behaviour 
associated with ASD. However, as discussed below, differences in parental reporting 
of associated behaviours may also explain the findings.  
The proportion of children with autism-related behaviours was greater in the 
later cohort. Adjusting for increases in autism-related traits led to a decline in the 
relative odds of being diagnosed with ASD in the later cohort, with the relationship 
becoming non-significant. This suggests that the observed increases in number of 
children with behaviours associated with autism partially accounted for the increased 
diagnosis rates. This chimes with experience of teachers: a UK survey found 67% 
thought there were more children with ASD in 2000 than 1995 (25). Parents have 
also suggested rates of autism-related behaviour are greater than before (8). 
A recent study of a population-based cohort of over 2 million children 
estimated that substantially more of the risk of ASD is conferred by environmental 
factors than previously thought (26). It is conceivable that novel environmental 
factors such as social changes with biological implications, for example, couples 
having children later could influence trends in population prevalence of ASD (27). A 
recent review of time trends in child and adolescent mental health (11) has 
15 
 
highlighted that even where diagnostic criteria and practice have changed, there may 
still be strong evidence for real additional change in population prevalence (e.g. with 
respect to adolescent depression and anxiety).  
Nevertheless, caution is needed in interpreting the findings. ‘Reporting drift’ is 
the process through which parent and teacher reporting of behaviours and 
impairment may change across time. For example, there may be more societal 
emphasis on impaired social skills and problems with communication at the later 
time point. A difficulty in the interpretation of time trend findings is the separation of 
“true changes” from reporting drift (even in general population cross-cohort 
comparisons such as this where other methodological artefacts such as changes in 
diagnostic practice are controlled). How do we know what is a facet of change in 
symptomatology over time, and what is an artefact of changing standards of 
reporting? The current study used a variety of sources, parent-report, teacher report, 
and school assessments. Such a variety of sources is acknowledged to be more 
likely to give a ‘true’ picture of underlying behaviours. However, reporting drift cannot 
be ruled out as parents and teachers may still have systematically over-identified 
autism-type difficulties in the later cohort.  
Strengths and Limitations 
The two cohorts, although both population-based, had differing geographical 
reach and sampling frames. The MCS was representative of the UK population as a 
whole. The ALSPAC survey, despite being a regional study was broadly 
representative of the UK population at the 1991 census in most aspects of social 
demography (14) but differences in ASD diagnostic practice by region cannot be 
discounted. There was a lack of geographical variation in ASD diagnosis in MCS, 
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albeit by country not county, but data from US suggest there may be variations in 
ASD diagnosis across regions (28) that we could not account for. The study’s 
strengths include the use of population-based samples, where non-response weights 
were applied to account for known predictors of attrition, with no evidence for 
differential selective non-response between cohorts. The measures used were 
closely similar, although they were not always administered and recorded in an 
identical way. For example, the ASD diagnosis question was worded differently (see 
Figure 1) and asked via postal questionnaire in the ALSPAC cohort and via face-to-
face questionnaire for the MCS cohort. Replication of the findings is therefore 
important. 
Our findings would have been more relevant to the ASD prevalence question 
if well validated autism-specific measures, (e.g. the Autism Diagnostic Observation 
Schedule) were used, but no such measures are presently available across UK 
population cohorts. The trait scores for the two cohorts were used to generate a 
CATS scale with reasonable sensitivity and specificity, making it a suitable, although 
limited, indicator of some ASD traits. We are not claiming that the CATS scale 
represented ‘autism’ but a child with high CATS’ tail likely had poor communication, 
was less able to sustain peer relationships, and/or was afraid of new situations, 
and/or did not share easily or empathise well.  However, none of the items asked 
about restricted interests, repetitive behaviours, or stereotypic behaviours, which 
represent a key facet of the ASD phenotype. High CATS was used to characterise 
behaviours associated with ASD, but is not a validated ASD measure. The CATS 
scale simply maximised the data available in a way that optimised our ability to 
answer the study questions, which the individual scales could not.  
17 
 
At present, like-for-like comparisons of unselected cohorts are lacking with 
respect to ASD. Lundström et al. did assess the time-trend in Sweden recently, but 
claim to have found no evidence of increasing numbers of children displaying the 
ASD phenotype over time (29). However these authors did not test for non-linear 
trends, which may have revealed a different result. They also report that a significant 
increase in mean scores for the autism phenotype did occur over time: but fail to 
elaborate in their discussion. We believe that our results indicate that the question 
cannot be conclusively answered. It is important for clinicians to be aware that the 
debate over increasing prevalence of ASD is ongoing; increasing rates of ASD 
diagnosis in the UK in the past may not be solely due to changes in diagnostic 
criteria and clinical practice. Our findings may reflect a true increase in population 
traits and behaviours associated with ASD. Alternatively, shifts in parent and teacher 
recognition and reporting of such traits may also explain the findings. Further 
research is needed to distinguish these two possibilities.   
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Figure 1: Steps in deriving parent-reported ASD diagnosis at age 7 in both 
cohorts 
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Figure 2: Distribution of composite autism-type symptom score (CATS) in both 
cohorts together n=15,750 
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Table 1: Proportions and mean values of variables at initial sample, and for 
respondents parents supplying ASD diagnosis data, both with and without weighting.   
Predictors of drop out 
 
sample at birth 
 
Included in study 
sample at follow-
up 
 
Included in study 
sample at follow-
up 
  
unweighted 
 
weighted 
 
ALSPAC  n 
 
n 
  
Mother age at childbirth. Mean 
(SD) 
14082 
27.98 
(6.10) 
2769 
28.63 
(6.31) 
28.25 (6.35) 
 
     
Mothers education (<A level %) 12340 64 7564 58 60 
A level % 
 
22  26 26 
Degree %  13  16 15 
      
Mothers social class- non manual 
% 
9997 80 6482 83 81 
Fathers social class- non manual 
% 
10904 56 6940 61 58 
MCS       
25 
 
Mother age at childbirth. Mean 
(SD) 
18542 28.32 
(5.96) 
7082 28.91 
(6.83) 
28.54 (6.81) 
Mothers education (<A level %) 14343 57 10746 54 57 
A level %  12  12 12 
Degree %  31  33 31 
Mothers social class- professional 
or intermediate % 
16356 48 11983 51 51 
Fathers social class- professional 
or intermediate % 
12,911 43 9906 46 47 
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Table 2:  
Characteristics of children with parent-reported ASD diagnosis (n=291) by cohort. 
 
 ALSPAC 
1997/8 
Total 
n=82 
MCS 
2007/8 
Total 
n=209 
Test of difference 
OR (95% CI) 
p 
 
Gender, female % 
 
26 
 
18 
 
0.95 (0.89, 1.01) 
 
0.12 
Age of diagnosis 1  
early (<5 years) % 
 
72 
 
60 
 
0.56  (0.27, 1.18) 
 
0.13 
 
1 29 ALSPAC parents did not give date of ASD diagnosis: 53 records available  
 
 
 
 
 
